A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Moxifloxacin Impurity F (Moxifloxacin hydrochloride EP impurity F) | Moxifloxacin Impurity F (Moxifloxacin hydrochloride EP impurity F). Uses: For analytical and research use. CAS No. 721970-37-2. Molecular formula: C22H26FN3O4. Mole weight: 415.46. Catalog: APB721970372. |  |
| Moxifloxacin Impurity G | Moxifloxacin Impurity G. Uses: For analytical and research use. CAS No. 112811-71-9. Molecular formula: C16H15F2NO4. Mole weight: 323.29. Catalog: APB112811719. | |
| Moxifloxacin Impurity H | Moxifloxacin Impurity H. Uses: For analytical and research use. CAS No. 147459-51-6. Molecular formula: C7H14N2. Mole weight: 126.2. Catalog: APB147459516. | |
| Moxifloxacin Impurity I | Moxifloxacin Impurity I. Uses: For analytical and research use. CAS No. 139693-52-0. Molecular formula: C19H17F2NO8. Mole weight: 425.34. Catalog: APB139693520. | |
| Moxifloxacin Impurity J | Moxifloxacin Impurity J. Uses: For analytical and research use. Alternative Names: 1-Cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid. CAS No. 112811-72-0. Molecular formula: C14H11F2NO4. Mole weight: 295.24. Catalog: APB112811720. | |
| Moxifloxacin Impurity K | Moxifloxacin Impurity K. Uses: For analytical and research use. CAS No. 2489671-14-7. Molecular formula: C17H18FNO5. Mole weight: 335.33. Catalog: APB2489671147. | |
| Moxifloxacin Impurity L | Moxifloxacin Impurity L. Uses: For analytical and research use. Alternative Names: 7-Amino-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic Acid. CAS No. 172426-88-9. Molecular formula: C14H13FN2O4. Mole weight: 292.26. Catalog: APB172426889. | |
| Moxifloxacin Impurity M | Moxifloxacin Impurity M. Uses: For analytical and research use. Molecular formula: C21H24FN3O4. Mole weight: 401.44. Catalog: APB08572. | |
| Moxifloxacin Impurity N | Moxifloxacin Impurity N. Uses: For analytical and research use. Molecular formula: C35H34F2N4O8. Mole weight: 676.66. Catalog: APB08573. | |
| Moxifloxacin Impurity O | Moxifloxacin Impurity O. Uses: For analytical and research use. Molecular formula: C17H18FNO5. Mole weight: 335.33. Catalog: APB08574. | |
| Moxifloxacin Impurity P (Moxifloxacin hydrochloride EP impurity G) | Moxifloxacin Impurity P (Moxifloxacin hydrochloride EP impurity G). Uses: For analytical and research use. CAS No. 268545-13-7. Molecular formula: C21H24FN3O4. Mole weight: 401.44. Catalog: APB268545137. | |
| Moxifloxacin Impurity Q | Moxifloxacin Impurity Q. Uses: For analytical and research use. CAS No. 1329836-33-0. Molecular formula: C16H15F2NO4. Mole weight: 323.3. Catalog: APB1329836330. | |
| Moxifloxacin Impurity R | Moxifloxacin Impurity R. Uses: For analytical and research use. CAS No. 452092-31-8. Molecular formula: C15H13F2NO4. Mole weight: 309.27. Catalog: APB452092318. | |
| Moxifloxacin Impurity S | Moxifloxacin Impurity S. Uses: For analytical and research use. CAS No. 2205053-60-5. Molecular formula: C21H24FN3O4. Mole weight: 401.44. Catalog: APB2205053605. | |
| Moxifloxacin Impurity T | Moxifloxacin Impurity T. Uses: For analytical and research use. CAS No. 1797982-51-4. Molecular formula: C16H16FNO5. Mole weight: 321.3. Catalog: APB1797982514. | |
| Moxifloxacin Impurity U | Moxifloxacin Impurity U. Uses: For analytical and research use. CAS No. 172602-83-4. Molecular formula: C17H17F2NO4. Mole weight: 337.32. Catalog: APB172602834. | |
| Moxifloxacin Impurity V | Moxifloxacin Impurity V. Uses: For analytical and research use. CAS No. 112811-67-3. Molecular formula: C15H15F3O6. Mole weight: 348.27. Catalog: APB112811673. | |
| Moxifloxacin Impurity W | Moxifloxacin Impurity W. Uses: For analytical and research use. CAS No. 442882-27-1. Molecular formula: C15H12N2O3. Mole weight: 268.27. Catalog: APB442882271. | |
| Moxifloxacin Impurity Y | Moxifloxacin Impurity Y. Uses: For analytical and research use. CAS No. 2445515-66-0. Molecular formula: C21H25N3O5. Mole weight: 399.45. Catalog: APB2445515660. | |
| Moxifloxacin Impurity Z | Moxifloxacin Impurity Z. Uses: For analytical and research use. Alternative Names: 1-cyclopropyl-6,7-difluoro-8-hydroxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid. CAS No. 154093-72-8. Molecular formula: C13H9F2NO4. Mole weight: 281.21. Catalog: APB154093728. | |
| Moxifloxacin N-Sulfate Disodium Salt | A sulfometabolite of Moxifloxacin. Group: Biochemicals. Alternative Names: 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-1-sulfo-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic Acid Disodium Salt. Grades: Highly Purified. Pack Sizes: 10mg. US Biological Life Sciences. |  Worldwide |
| Moxifloxacin Related Compound A | Moxifloxacin Related Compound A. Uses: For analytical and research use. CAS No. 151213-15-9. Mole weight: 389.40. Catalog: AP151213159. | |
| Moxifloxacin Related Compound A (HCl salt form) | An impurity of Moxifloxacin. Moxifloxacin is an antibiotic used to treat bacterial infenctions such as community acquired pneumonia, complicated skin infections and complicated intra-abdominal infections. Grades: 95%. CAS No. 151282-23-4. Molecular formula: C20H22ClF2N3O3. Mole weight: 425.863. |  |
| Moxifloxacin Related Compound D | Moxifloxacin Related Compound D. Uses: For analytical and research use. CAS No. 1029364-77-9. Mole weight: 401.43. Catalog: AP1029364779. | |
| Moxifloxacin Related Compound E | Moxifloxacin Related Compound E. Uses: For analytical and research use. CAS No. 721970-36-1 (free base). Mole weight: 423.87. Catalog: ALP721970361. | |
| Moxifloxacin Related Compound F | Moxifloxacin Related Compound F. Uses: For analytical and research use. CAS No. 1179992-99-4. Catalog: AP1179992994. | |
| Moxifloxacin Related Compound G | An impurity of Moxifloxacin. Moxifloxacin is an antibiotic used to treat bacterial infenctions such as community acquired pneumonia, complicated skin infections and complicated intra-abdominal infections. Alternative Names: Moxifloxacin RR-Isomer (HCl salt form); 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid monohydrochloride. Grades: 95%. CAS No. 1394029-14-1. Molecular formula: C21H25ClFN3O4. Mole weight: 437.89. | |
| Moxifloxacin (Standard) | Moxifloxacin (Standard) is the analytical standard of Moxifloxacin. This product is intended for research and analytical applications. Moxifloxacin is an orally active 8-methoxyquinolone antimicrobial for use in the treatment of acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia[1][2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: BAY 12-8039 free base (Standard). CAS No. 151096-09-2. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-66011AR. |  |
| Moxilubant | Moxilubant (CGS 25019C free base) is an orally active BLT1 antagonist. Moxilubant inhibits LTB4 signaling with a potency of 2-4 nM. Moxilubant blocks LTB4-induced neutrophil functions. Moxilubant inhibits ear edema and neutrophil infiltration in mice. Moxilubant can be used in research related to chronic obstructive pulmonary disease[1][2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: CGS 25019C free base. CAS No. 146978-48-5. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg. Product ID: HY-106929. | |
| Moxisylyte hydrochloride | Moxisylyte hydrochloride is alpha 1-adrenoceptor antagonist. It can vasodilates cerebral vessels without reducing blood pressure. It is used as peripheral vasodilator. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine. It is used as sympathomimetic agents. It has been listed. Uses: Moxisylyte hydrochloride is used as peripheral vasodilator. it is also used as sympathomimetic agents. Alternative Names: Carvacrol,5-[2-(dimethylamino)ethoxy]-, acetate (ester), hydrochloride (8CI);Phenol,4-[2-(dimethylamino)ethoxy]-2-methyl-5-(1-methylethyl)-, acetate (ester),hydrochloride (9CI);4-(2-Dimethylaminoethoxy)-5-isopropyl-2-methylphenyl acetatehydrochloride;Opilon hydrochloride;(2-(4-acetoxy-2-isopropyl-5-methylphenoxy)ethyl)dimethylaminehydrochloride;5-(2-(N,N-dimethylamino)ethoxy)carvacrolacetatehydrochloride;Arlitene;Vasoklin;Moxisylyte HCl;[4-[2-(dimethylamino)ethoxy]-2-methyl-5-propan-2-ylphenyl] acetate;hydrochloride;Thymoxamine hydrochloride. Grades: >98 %. CAS No. 964-52-3. Molecular formula: C16H26ClNO3. Mole weight: 315.84. | |
| Moxonidine | Moxonidine is an antihypertensive agent. Group: Biochemicals. Alternative Names: 4-Chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-6-methoxy-2-methyl-5-pyrimidinamine; 2-(6-Chloro-4-methoxy-2-methylpyrimidin-5-ylamino)-2-imidazoline; Lomox; Moxon; Norcynt; Normoxocin; Nucynt; Physiotens. Grades: Highly Purified. CAS No. 75438-57-2. Pack Sizes: 25mg. US Biological Life Sciences. | Worldwide |
| Moxonidine EP impurity B | Moxonidine EP impurity B. Uses: For analytical and research use. CAS No. 75439-01-9. Molecular formula: C10H15N5O2. Mole weight: 237.26. Catalog: APB75439019. | |
| Moxonidine EP impurity C | Moxonidine EP impurity C. Uses: For analytical and research use. CAS No. 352457-34-2. Molecular formula: C9H13N5O2. Mole weight: 223.24. Catalog: APB352457342. | |
| Moxonidine EP impurity D | Moxonidine EP impurity D. Uses: For analytical and research use. CAS No. 352457-33-1. Molecular formula: C8H10ClN5O. Mole weight: 227.65. Catalog: APB352457331. | |
| Moxonidine hydrochloride | Moxonidine (BDF5895) hydrochloride is an orally active imidazoline type 1 receptor (I1-R) agonist. Moxonidine hydrochloride activates imidazoline I1 receptors and α2 adrenoceptors, affecting oxidized low-density lipoprotein uptake. Moxonidine hydrochloride reduces atherosclerotic lesions and lowers blood pressure. Moxonidine hydrochloride can be used in the study of hypertension, heart failure, and atherosclerosis[1][2][3][4][5][6][7]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: BDF5895 hydrochloride. CAS No. 75536-04-8. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-B0374A. | |
| Moxonidine hydrochloride | Moxonidine hydrochloride. Group: Biochemicals. Grades: Purified. CAS No. 75536-04-8. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
| Moxonidine impurity 2 | Moxonidine impurity 2. Uses: For analytical and research use. Molecular formula: C9H10ClN7O3. Mole weight: 299.68. Catalog: APB08677. | |
| Moxonidine impurity 3 | Moxonidine impurity 3. Uses: For analytical and research use. Molecular formula: C9H11ClN6O2. Mole weight: 270.68. Catalog: APB08678. | |
| Moxonidine impurity 4 | Moxonidine impurity 4. Uses: For analytical and research use. Molecular formula: C9H10ClN7O3. Mole weight: 299.68. Catalog: APB08679. | |
| Mozavaptan | Mozavaptan (OPC-31260) is a benzazepine derivative and a potent, selective, competitive and orally active vasopressin V2 receptor antagonist with an IC50 of 14 nM. Mozavaptan shows ~85-fold selectivity for V2 receptor over V1 receptor (IC50 of 1.2 μM), and can antagonize the antidiuretic action of arginine vasopressin (AVP) in vivo. Mozavaptan has the potential for hyponatremia, syndrome of inappropriate antidiuretic hormone (SIADH), and congestive heart failure treatment[1][2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: OPC-31260. CAS No. 137975-06-5. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg; 250 mg. Product ID: HY-18346. | |
| Mozavaptan hydrochloride | Mozavaptan hydrochloride (OPC-31260 hydrochloride) is a benzazepine derivative and a potent, selective, competitive and orally active vasopressin V2 receptor antagonist with an IC50 of 14 nM. Mozavaptan hydrochloride shows ~85-fold selectivity for V2 receptor over V1 receptor (IC50 of 1.2 μM), and can antagonize the antidiuretic action of arginine vasopressin (AVP) in vivo. Mozavaptan hydrochloride has the potential for hyponatremia, syndrome of inappropriate antidiuretic hormone (SIADH), and congestive heart failure treatment[1][2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: OPC-31260 hydrochloride. CAS No. 138470-70-9. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-123593. | |
| MP07-66 | MP07-66, a FTY720 analogue, is devoid of immunosuppressive effects and shows promising antitumor effects in chronic lymphocytic leukemia by disruption of the SET-PP2A complex leading to PP2A reactivation[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 1938056-90-6. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-123794. | |
| MP7 | MP7 (PDK1 inhibitor) is a phosphoinositide-dependent kinase-1 (PDK1) inhibitor. Uses: Scientific research. Category: Signaling pathways. Alternative Names: PDK1 inhibitor. CAS No. 1001409-50-2. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-14440. | |
| MP-A08 | MP-A08 is a cell permeable selective inhibitor of sphingosine kinase 2 (Ki=6.9 μM) and 1 (Ki=27 μM) with little affinity for other kinases. In vitro: inhibits cellular S1P production and increases sphingosine and ceramide levels. Alternative Names: MP-A08; MP A08; MPA08; NSC-122314; NSC 122314; NSC122314; 4-methyl-N-[2-[[2-[(4-methylphenyl)sulfonylamino]phenyl]iminomethyl]phenyl]benzenesulfonamideMP-A08NSC122314AC1L9JETAmbcb5562335SCHEMBL17443540MCULE-6662772127N-[2-[[2-(Tosylamino)benzylidene]amino]phenyl]-4-methylbenzenesulfonamideMP A08|NSC 1223. CAS No. 219832-49-2. Molecular formula: C27H25N3O4S2. Mole weight: 519.64. | |
| MPB-MMAF | MPB-MMAF is a drug-linker conjugate for ADC by using Monomethylauristatin F (MMAF,a potent tubulin polymerization inhibitor), linked via MPB. Molecular formula: C53H76N6O11. Mole weight: 973.22. | |
| MPC-3100 | MPC-3100 is a recently discovered fully synthetic purine-based Hsp90 Inhibitor exhibiting anticancer properties. Group: Biochemicals. Alternative Names: (2S)-1-[4-[2-[6-Amino-8-[(6-bromo-1,3-benzodioxol-5-yl)thio]-9H-purin-9-yl]ethyl]-1-piperidinyl]-2-hydroxy-1-propanone. Grades: Highly Purified. CAS No. 958025-66-6. Pack Sizes: 5mg. US Biological Life Sciences. | Worldwide |
| MPC 6827 hydrochloride | MPC 6827 hydrochloride. Group: Biochemicals. Grades: Purified. CAS No. 917369-31-4. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
| MPDC | MPDC. Group: Biochemicals. Grades: Purified. CAS No. 159262-32-5. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| MPDDA | MPDDA. Mole weight: 226. |  |
| MPDL3280A | A human, Fc optimized, monoclonal antibody directed against the protein ligand PD-L1 (programmed cell death-1 ligand 1), with potential immune checkpoint inhibitory and antineoplastic activities. Atezolizumab binds to PD-L1, blocking its binding to and activation of its receptor programmed death 1 (PD-1) expressed on activated T-cells, which may enhance the T-cell-mediated immune response to neoplasms and reverse T-cell inactivation. In addition, by binding to PD-L1, atezolizumab also prevents binding of this ligand to B7.1 expressed on activated T cells, which further enhances the T-cell-mediated immune response. PD-L1 is overexpressed on many human cancer cell types and on various tumor-infiltrating immune cells. PD-L1 binding to PD-1 on T-cells suppresses the immune system and results in increased immune evasion. PD-1, a transmembrane protein, is a negative regulator of the immune system that limits the expansion and survival of CD8+ T cells. The Fc region of atezolizumab is modified in such a way that it does not induce either antibody-dependent cytotoxicity (ADCC) or complement-dependent cytotoxicity (CDC). Alternative Names: Atezolizumab; RG 7446; RO 5541267; RG7446; RO5541267; RG-7446; RO-5541267; TECENTRIQ. CAS No. 1380723-44-3. | |
| m-PEG10000-NHS ester | m-PEG10000-NHS ester is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: mPEG10000-SC; mPEG10000-Succinimidyl ester. CAS No. 92451-01-9. Pack Sizes: 25 mg; 50 mg; 100 mg; 250 mg; 500 mg; 1 g. Product ID: HY-140699. | |
| mPEG1000-amine | mPEG1000-amine (mPEG1000-NH2) is a class of functionalized polymers composed of a methoxy-terminated polyethylene glycol backbone and a terminal primary amine group. mPEG1000-amine serves as an important intermediate for constructing functionalized nanocarriers, modifying proteins or polypeptides, and developing novel drug delivery systems. Uses: Scientific research. Category: Signaling pathways. Alternative Names: mPEG1000-NH2. CAS No. 80506-64-5. Pack Sizes: 100 mg; 500 mg. Product ID: HY-140675. | |
| m-PEG10-CH2COOH | m-PEG10-CH2COOH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 908258-58-2. Pack Sizes: 100 mg; 250 mg; 1 g; 5 g. Product ID: HY-133285. | |
| mPEG10K-Propionaldehyde | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Alternative Names: mPEG-Propionaldehyde, mPEG-ALD, Methoxy-PEG-Propionaldehyde. Mole weight: average Mn 10000. | |
| mPEG10K-Succinimidyl Carboxymethyl Ester | Methoxy PEG NHS Ester (SCM PEG). Amine reactive PEG towards the amino groups of lysine(s) on proteins or other biologics; reaction occurs at room temperature in <1hr at pH 7-8. Stable linker between PEG and NHS ester. Alternative Names: mPEG-Succinimidyl Carboxymethyl Ester. Mole weight: average Mn 10000. | |
| m-PEG12-acid | m-PEG12-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 2135793-73-4. Pack Sizes: 50 mg; 100 mg; 250 mg; 1 g; 5 g; 10 g. Product ID: HY-135820. | |
| mPEG12-Acrylate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. | |
| mPEG12-Azide | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Mole weight: average Mn 12000. | |
| m-PEG12-COOH | m-PEG12-COOH is a PEG linker containing a terminal carboxylic acid. The terminal carboxylic acid can react with primary amine groups in the presence of activators (e.g. EDC, or HATU) to form a stable amide bond. The hydrophilic PEG spacer increases solubility in aqueous media. Alternative Names: mPEG11-CH2CH2COOH; mPEG12-acid; mPEG11-propionic acid; m-PEG12-acid; 2,5,8,11,14,17,20,23,26,29,32,35-dodecaoxaoctatriacontan-38-oic acid; alpha-Methoxy-omega-propioic acid undeca(ethylene glycol); O-(2-Carboxyethyl)-O'-methyl-undecaethylene glycol; 4,7,10,13,16,19,22,25,28,31,34,37-Dodecaoxaoctatriacontanoic acid. Grades: >97%. CAS No. 2135793-73-4. Molecular formula: C26H52O14. Mole weight: 588.68. | |
| mPEG12-NH2 | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Molecular formula: C25H53NO12. Mole weight: 559.7g/mol. IUPAC Name: 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanamine. SMILES: COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCN. InChI: InChI=1S/C25H53NO12/c1-27-4-5-29-8-9-31-12-13-33-16-17-35-20-21-37-24-25-38-23-22-36-19-18-34-15-14-32-11-10-30-7-6-28-3-2-26/h2-26H2,1H3. | |
| m-PEG12-NHS ester | m-PEG12-NHS ester is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 2207596-93-6. Pack Sizes: 100 mg; 500 mg. Product ID: HY-141106. | |
| mPEG12-OH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Alternative Names: Methoxy-PEG12-Hydroxyl. Molecular formula: C25H52O13. Mole weight: 560.7g/mol. IUPAC Name: 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol. SMILES: [H]OCCOC. InChI: 1S/C3H8O2/c1-5-3-2-4/h4H,2-3H2,1H3. | |
| m-PEG12-OTs | m-PEG12-Ots is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 2103241-71-8. Pack Sizes: 1 g; 5 g. Product ID: HY-161020. | |
| mPEG12-Propionic acid | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Alternative Names: mPEG12-PA, methoxy-PEG-Propionic acid. SMILES: OC(CCOCCOC)=O. InChI: 1S/C6H12O4/c1-9-4-5-10-3-2-6(7)8/h2-5H2,1H3,(H,7,8). | |
| mPEG12-SH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Molecular formula: C25H52O12S. Mole weight: 576.7g/mol. IUPAC Name: 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanethiol. SMILES: COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCS. InChI: InChI=1S/C25H52O12S/c1-26-2-3-27-4-5-28-6-7-29-8-9-30-10-11-31-12-13-32-14-15-33-16-17-34-18-19-35-20-21-36-22-23-37-24-25-38/h38H,2-25H2,1H3. | |
| mPEG16-NH2 | mPEG16-NH2. CAS No. 907577-50-8. Molecular formula: C33H69NO16. Mole weight: 735.9g/mol. IUPAC Name: 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanamine. SMILES: COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCN. InChI: InChI=1S/C33H69NO16/c1-35-4-5-37-8-9-39-12-13-41-16-17-43-20-21-45-24-25-47-28-29-49-32-33-50-31-30-48-27-26-46-23-22-44-19-18-42-15-14-40-11-10-38-7-6-36-3-2-34/h2-34H2,1H3. | |
| mPEG2000-amine | mPEG2000-amine (mPEG2000-NH2) is a class of functionalized polymers composed of a methoxy-terminated polyethylene glycol backbone and a terminal primary amine group. mPEG2000-amine serves as an important intermediate for constructing functionalized nanocarriers, modifying proteins or polypeptides, and developing novel drug delivery systems. Uses: Scientific research. Category: Signaling pathways. Alternative Names: mPEG2000-NH2. CAS No. 80506-64-5. Pack Sizes: 50 mg; 100 mg; 250 mg; 1 g; 5 g. Product ID: HY-140676. | |
| mPEG2000C-DMG | mPEG2000C-DMG, a polyethylene glycol derivative renowned for its pivotal role in surface modification for drug delivery and as a crucial linker in antibody-drug conjugates. Its widespread application in the realm of nanoparticle-based therapies, especially in the combat against cancer and various maladies, underscores its significance in the pharmaceutical landscape. Alternative Names: α-(3'-{[1,2-di(myristyloxy)propanoxy]carbonylamino}propyl)-ω-methoxy, polyoxyethylene. Grades: >97%. CAS No. 1019000-64-6. Molecular formula: (C2H4O)nC36H73NO5. | |
| mPEG2000-DMG | DMG-PEG 2000 is used for the preparation of liposome for siRNA delivery with improved transfection efficiency in vitro. DMG-PEG 2000 is also used for the lipid nanoparticle for an oral plasmid DNA delivery approach in vivo through a facile surface modification to improve the mucus permeability and delivery efficiency of the nanoparticles[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 160743-62-4. Pack Sizes: 25 mg; 50 mg; 100 mg; 500 mg. Product ID: HY-112764. | |
| MPEG-2000-DMPE | MPEG-2000-DMPE is a phospholipid containing a polyether unit. It can be used for PEG-biochemical conjugation, and be utilized in micelles, liposomes, and other lipid-based drug carriers. Alternative Names: N-(Carbonyl-methoxypolyethylenglycol 2000)-1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine sodium salt; 1,2-Dimyristoyl-sn-glycero-3-phosphoethanolamine, Carbonyl-methoxypolyethylenglycol 2000 labeled. CAS No. 384835-59-0. Molecular formula: (C2H4O)nC35H68NO10P. | |
Our database is helping our users find suppliers everyday.
